Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The American Journal of Tropical Medicine and Hygiene|June 19, 2003
Short report: persistence of tumor necrosis factor-alpha in situ after lesion healing in mucosal leishmaniasisValdir S Amato, Heitor F Júnior Andrade, Vicente Amato Neto, et al.
The American Journal of Tropical Medicine and Hygiene|November 4, 2011
Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis?Valdir S Amato, Felipe F Tuon, Raphael A Camargo, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|January 30, 2020
Tegumentary leishmaniasis mimicking visceralization in a cirrhotic patient: atypical cutaneous lesions and local immunological featuresSebastian Vernal, Yuri Casal, Lucas T Vieira, et al.
The American Journal of Tropical Medicine and Hygiene|November 30, 2016
Disease Severity Prediction by Spirometry in Adults with Visceral Leishmaniasis from Minas Gerais, BrazilIsabel A Maia, Frank S Bezerra, André Luis Pereira de Albuquerque, et al.
The American Journal of Tropical Medicine and Hygiene|September 3, 2010
Mucosal leishmaniasis and abnormalities on computed tomographic scans of paranasal sinusesRaphael A Camargo, Felipe F Tuon, Daniel V Sumi, et al.
Acta Tropica|September 8, 2004
Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patientsValdir S Amato, Ana Rabello, Alexandre Rotondo-Silva, et al.
BMC Infectious Diseases|December 22, 2010
High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral loadJoanna R Santos-Oliveira, Carmem B W Giacoia-Gripp, Priscilla Alexandrino de Oliveira, et al.
BMC Infectious Diseases|April 26, 2007
IFNG +874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma productionGuilherme Inocêncio Matos, Claudia de J Fernandes Covas, Rita de Cássia Bittar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2023
A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in BrazilMarcelo R Lyra, Liliane F A Oliveira, Armando O Schubach, et al.
Pageof 1